{"product_id":"hemophilia-and-hemostasis-isbn-9780470659762","title":"Hemophilia and Hemostasis","description":"\u003cp\u003eThere is a general need amongst healthcare professionals for practical advice on the management of patients with bleeding disorders. This book is an essential resource for all those working in the fields of coagulation, hemostasis and thrombosis. It covers the major cases one might encounter in diagnosing, managing and treating hemophilia and hemostasis. It provides a practical and informative guide to the broad range of topics concerning both bleeding and clotting disorders.\u003c\/p\u003e \u003cp\u003eThe book is divided into major chapter sections depending on the type of bleeding disorder it fits into. Each chapter includes a brief overview of the disorder covering: history of the disorder; molecular basis of the disorder; class presentation; genetics; current laboratory tests and monitoring. Cases associated with each disorder are presented alongside practical questions and answers from a wide range of contributors. As practice can vary from center to center, controversial areas are clearly marked and discussed throughout.\u003c\/p\u003e \u003cp\u003eNew to this edition: coverage of the newer techniques; newer treatment modalities; new oral anticoagulants; update on hemophilia management; more on ITP and greater coverage of new cases as suggested by reviewers.\u003c\/p\u003e  \u003cb\u003e\u003ci\u003eList of Contributors\u003c\/i\u003e\u003c\/b\u003e  \u003cp\u003e\u003cb\u003e\u003ci\u003eForeword\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 1: HAEMOPHILIA A AND HAEMOPHILIA B\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eGeneral Overview\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe hemophilic ankle: an update\u003c\/p\u003e \u003cp\u003eThe haemophilic knee: An update\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eHaemophilia with Inhibitors\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eInhibitor patient requiring high dose therapy with rVIIa as well as sequential therapy with FEIBA.\u003c\/p\u003e \u003cp\u003eProphylactic therapy in a patient with a high titer inhibitor\u003c\/p\u003e \u003cp\u003eImmune Tolerance Induction\u003c\/p\u003e \u003cp\u003eMonitoring during ITI\u003c\/p\u003e \u003cp\u003eFIX inhibitors\u003c\/p\u003e \u003cp\u003eSevere Hemophilia B with high response inhibitor and anaphylactic reaction to factor IX\u003c\/p\u003e \u003cp\u003eInhibitor patient and dental surgery\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eHaemophilic treatment for procedures\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDVT prophylaxis in patients with hemophilia A undergoing orthopedic surgery\u003c\/p\u003e \u003cp\u003eProstate Surgery and Hemophilia\u003c\/p\u003e \u003cp\u003eMild Hemophilia and Intraocular Injections\u003c\/p\u003e \u003cp\u003eEndoscopy\/colonoscopy and Hemophilia\u003c\/p\u003e \u003cp\u003eDialysis and Hemophilia\u003c\/p\u003e \u003cp\u003eCircumcision\u003c\/p\u003e \u003cp\u003ePK Studies prior to Orthopedic Surgery\u003c\/p\u003e \u003cp\u003eCompartment Syndrome\u003c\/p\u003e \u003cp\u003eSuccessful eradication of factor VIII inhibitor in patient with mild Hemophilia A prior to\u003c\/p\u003e \u003cp\u003ehemipelvectomy for extensive hemophilic pseudotumor\u003c\/p\u003e \u003cp\u003eCoronary artery disease and hemophilia\u003c\/p\u003e \u003cp\u003eValve Replacement and Hemophilia\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eTreatment for other conditions\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThyroid biopsy and Hemophilia\u003c\/p\u003e \u003cp\u003eAtrial Fibrillation and bleeding disorders\u003c\/p\u003e \u003cp\u003eChronic Upper GI bleeding and hemophilia\u003c\/p\u003e \u003cp\u003eHematuria\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eOther issues in haemophilia care\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eReproductive Options for Hemophilia A Carriers\u003c\/p\u003e \u003cp\u003eMild Hemophilia A with Discrepant FVIII activity levels\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eCompund Diagnoses\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHemophilia A with tuberous sclerosis and CNS bleed\u003c\/p\u003e \u003cp\u003eFamilial Risk Assessment for Individuals with Hemophilia A and von Willebrand Disease\u003c\/p\u003e \u003cp\u003eHemophilia A and HHT\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 2: VON WILLEBRAND DISEASE\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eManagement during procedures\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eType I VWD Tonsillectomy\u003c\/p\u003e \u003cp\u003eVWD and Dental surgery\u003c\/p\u003e \u003cp\u003eVWD and GI surgery\u003c\/p\u003e \u003cp\u003eVWD and Obstetric\/Gynecologic Procedures\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003eRare forms of Von Willebrand\u003c\/i\u003e\u003c\/b\u003e \u003cb\u003e\u003ci\u003eDisease\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eType 2A VWD and recurrent GI bleeding\u003c\/p\u003e \u003cp\u003eType 2B VWD and Thoracic Surgery\u003c\/p\u003e \u003cp\u003eVon Willebrand disease 2N\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 3: OTHER BLEEDING DISORDERS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eProthrombin deficiency\u003c\/p\u003e \u003cp\u003eFactor V deficiency\u003c\/p\u003e \u003cp\u003eFactor VII deficiency\u003c\/p\u003e \u003cp\u003eFX deficiency\u003c\/p\u003e \u003cp\u003eFactor XI deficiency\u003c\/p\u003e \u003cp\u003eFactor XIII deficiency\u003c\/p\u003e \u003cp\u003eCombined factor V and factor VIII deficiency 1, 2\u003c\/p\u003e \u003cp\u003eGlanzmann Thrombaesthenia\u003c\/p\u003e \u003cp\u003eGardner-Diamond syndrome and VWD\u003c\/p\u003e \u003cp\u003eQualitative Platelet Disorder—QPD\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 4: ACQUIRED BLEEDING DISORDERS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAcquired FVIII inhibitor and B cell neoplasm\u003c\/p\u003e \u003cp\u003eFVIII inhibitor and lupus inhibitor\u003c\/p\u003e \u003cp\u003eAcquired VWD\u003c\/p\u003e \u003cp\u003eA woman with bleeding gums\u003c\/p\u003e \u003cp\u003eBleeding after cardiac surgery\u003c\/p\u003e \u003cp\u003eBleeding in a dialysis patient\u003c\/p\u003e \u003cp\u003eA woman with anemia and hematuria\u003c\/p\u003e \u003cp\u003eScalp bleeding in an older gentleman\u003c\/p\u003e \u003cp\u003eHyperfibrinolysis\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 5: THROMBOTIC DISORDERS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHeparin induced thrombocytopenia with thrombosis\u003c\/p\u003e \u003cp\u003eHeparin Skin Necrosis\u003c\/p\u003e \u003cp\u003eWarfarin skin necrosis\u003c\/p\u003e \u003cp\u003eThoracic outlet syndrome 3, 4\u003c\/p\u003e \u003cp\u003eAntithrombin Deficiency\u003c\/p\u003e \u003cp\u003eMay-Thurner syndrome\u003c\/p\u003e \u003cp\u003eThrombosis in a liver transplant patient\u003c\/p\u003e \u003cp\u003eCombined thrombophilia\u003c\/p\u003e \u003cp\u003eIndex\u003c\/p\u003e  \u003cp\u003e“Overall, this is an extremely well written book suitable for consultants, trainees and, postgraduates, and is a must for all medical college libraries.”  (\u003ci\u003eIndian Journal Medical Research\u003c\/i\u003e, 1 September 2013)\u003c\/p\u003e \u003cp\u003e“This is an important book, as there are not many on the management of hemophilia and hemostasis that use a structured, case-based approach.”  (\u003ci\u003eDoody’s\u003c\/i\u003e, 26 July 2013)\u003c\/p\u003e \u003cp\u003e“On the whole this book is a useful tool for daily practice, particularly for those planning to work outside of a haemophilia comprehensive care centre, where regular exposure to haemophilia is limited.”  (\u003ci\u003eHaem Trainee\u003c\/i\u003e, 1 April 2013)\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eAlice D. Ma\u003c\/strong\u003e, University of North Carolina, Chapel Hill, NC, USA. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eMiguel A. Escobar\u003c\/strong\u003e, University of Texas Health Science Center at Houston, Director, Gulf States Hemophilia and Thrombophilia Center, Houston, TX, USA. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHarold Roberts\u003c\/strong\u003e, MD, ex-Senior Associate Editor of the \u003cem\u003eJournal of Thrombosis and Hemostasis\u003c\/em\u003e and Chairman, Division of Hematology\/Oncology, University of North Carolina at Chapel Hill, Chapel Hill North Carolina, USA.\u003cbr\u003eDr Roberts, a Sarah Graham Kenan Professor of Medicine and Pathology at the UNC-Chapel Hill School of Medicine, earned his undergraduate and medical degrees from UNC-Chapel Hill, joined the faculty in 1962 and has served as Chief of the Division of Hematology and Director of the UNC-Chapel Hill Comprehensive Hemophilia Diagnostic and Treatment Center. He was also the Founding Director of the school's Center for Thrombosis and Hemostasis, which conducts research on blood clotting disorders related to cardiovascular disease and on bleeding disorders such as hemophilia. He has served on the editorial boards of \u003cem\u003eCurrent Opinion in Hematology\u003c\/em\u003e and \u003cem\u003eHematologic Pathology\u003c\/em\u003e, as well as being Senior Associate Editor of \u003cem\u003eThrombosis and Hemostasis\u003c\/em\u003e.\u003cbr\u003eExcellence in laboratory research and patient care has earned Dr. Roberts numerous awards: the French International Prize for Research on Hemophilia, the National Hemophilia Foundation's Kenneth M. Brinkhous Award for Excellence in Clinical Research, and the Robert P. Grant Medal, the highest honor given by the International Society on Thrombosis and Hemostasis. The citation accompanying this award lauded him as \"one of the pioneers in the field of coagulation as well as being a leader in the Chapel Hill group which has brought so much to our present understanding of the subtleties in the mechanisms of coagulation. His contributions to our field have had a major impact, especially his outstanding work on the genetic basis of hemophilia.\"\u003cbr\u003eIn spring of 2000, Dr. Roberts received the UNC Medical Alumni Association's Distinguished Faculty Award and an honorary Doctor of Medicine degree from Lund University in Sweden.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989357674725,"sku":"NP9780470659762","price":110.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470659762.jpg?v=1761783800","url":"https:\/\/k12savings.com\/products\/hemophilia-and-hemostasis-isbn-9780470659762","provider":"K12savings","version":"1.0","type":"link"}